Kotyark Industries has been penalized ₹1,29,800 each by the National Stock Exchange of India Limited (NSE) and BSE Limited for failing to submit its unaudited financial results for the quarter ended June 30, 2026, within the prescribed timeline.

The company disclosed the imposition of fines on September 12, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The total monetary impact amounts to ₹2,59,600, inclusive of Goods and Services Tax (GST).

Reason for Delay

The submission deadline under Regulation 33 was August 14, 2026. Kotyark Industries cited the unwillingness of its existing statutory auditor, M/s. Manubhai & Shah LLP, to seek reappointment for a second term as the primary cause for the delay. The outgoing firm cited professional commitments and logistical constraints related to the location of the company’s operations in Rajasthan.

Consequently, the board proposed the appointment of M/s. Talati & Talati LLP as the new statutory auditor for FY27, subject to member approval at the 10th Annual General Meeting held on August 22, 2026. The new auditors could only undertake the limited review after their formal appointment, preventing the convening of the board meeting for result approval by the due date.

Compliance Status

The company informed the stock exchanges of the anticipated delay on August 13, 2026. It subsequently submitted the standalone and consolidated unaudited financial results along with the Limited Review Report on September 7, 2026.

Financial Impact Breakdown

The company stated that apart from these monetary penalties, there is no material impact on its operations or other activities. The matter will be placed before the Board of Directors at its next meeting as required by stock exchange communications.

Kotyark Industries reported a 9% year-on-year rise in consolidated net profit to ₹446.19 lakh for the quarter ended June 30, 2026 (Q1FY27). The company’s revenue from operations grew 11.5% to ₹9,198.08 lakh, driven by higher operational throughput despite ongoing regulatory scrutiny.

The Vadodara-based biofuel manufacturer published its first unaudited quarterly results since migrating from the SME platform to the Main Board on March 12, 2026. The Board of Directors approved the standalone and consolidated financial results on September 7, 2026, alongside the limited review report issued by statutory auditors Talati & Talati LLP.

Financial Performance

Consolidated revenue from operations stood at ₹9,198.08 lakh in Q1FY27, up from ₹8,246.49 lakh in the corresponding period of FY26. Standalone revenue also expanded, reaching ₹8,491.85 lakh compared to ₹7,673.71 lakh in Q1FY26.

Profit before tax for the consolidated entity was ₹747.20 lakh, an increase from ₹572.42 lakh in the prior-year quarter. After accounting for a total tax expense of ₹301.01 lakh, the net profit attributable to owners of the company was ₹383.77 lakh.

Earnings per share (basic and diluted) for the consolidated entity were ₹0.34, restated retrospectively following a 10:1 bonus share issue during the quarter. The standalone EPS was ₹0.09.

Operational and Regulatory Updates

The company disclosed that it ceased to be a partner in Asia Bio Fuels LLP and Parth Renewable Energy LLP effective April 1, 2026. These entities were de-merged from the consolidated financial results as the company no longer holds control over them.

Regulatory proceedings regarding the company’s registration with the Bio-Fuel Authority, Government of Rajasthan, remain pending. Authorities seized four storage tanks containing raw material (Veg Ester) at the Swaroopganj unit. However, the Rajasthan High Court permitted operations to continue to fulfill supply commitments to Oil Marketing Companies. Management stated there has been no loss of production or disruption in supplies.

What the Numbers Show

A divergence exists between standalone and consolidated profitability. While standalone net profit declined 7.9% YoY to ₹105.98 lakh due to higher cost of materials consumed relative to revenue, the consolidated net profit grew 9.1%. This growth is largely attributable to the performance of subsidiary Kotyark Bio Specialities Limited, which reported a net profit of ₹340.49 lakh for the quarter, significantly offsetting the parent company’s margin pressure.